Find a Laboratory Diagnostics Product
Select Disease
Laboratory Diagnostics
Select Manufacturer
Accumark
Bartels
Boronate Affinity HPLC
Cassette
ELISA
Hemolytic Anemia
IFA
Immunochromatography
Ion Exchange HPLC
Lateral Flow
Membrane Technologies
Premier Hb9210™
Premier Resolution
Trinity
TrinScreen
IFA
ImmuGlo™ IFA
ImmuLisa™ ELISA
Membrane Technologies
Search results
Showing 1 — 100 of 223 results
Product Name
Code
Kit
Disease
NCS One Step Multi-Line Screen Test Device (Urine)
NCS-12MOX
25 tests
Qualitative detection of multiple drugs and drug metabolites in human urine.
Code NCS-12MOX
Kit 25 tests
Disease Qualitative detection of multiple drugs and drug metabolites in human urine.
Intended Use

A rapid one step test device for testing combinations of the following drugs: Amphetamine, Barbiturates, Benzodiazepines, Cocaine, Marijuana, Methadone, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Oxycodone, Phencyclidine, and Tricyclic Antidepressant.

This test will detect other related compounds, please refer to the Analytical Specificity table in the package insert. This assay provides only a preliminary analytical test result. Gas chromatography/ mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

Technology

Rapid immunoassay

Determinations

25 tests

Application

Qualitative detection of multiple drugs and drug metabolites in human urine.

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

NCS12MOX ENFR

SDS Documents

Available Upon Request

Captia™ HSV 2 IgM
2325560/2325561
96 Tests/480 Tests
Herpes Simplex Virus (HSV) 2
Code 2325560/2325561
Kit 96 Tests/480 Tests
Disease Herpes Simplex Virus (HSV) 2
Intended Use

The Trinity Biotech Captia™ Herpes Simplex Virus type 2 (HSV 2) IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro semi-quantitative determination of IgM antibodies in human serum to Herpes simplex type 2 virus and as an aid in the diagnosis of herpes related diseases. High complexity test.

Benefits
Technology
ELISA
Determinations

96 Tests/480 Tests

Application

Infectious Diseases, Virology, Sexual Health, ToRCH

Registrations

FDA: Not Cleared
Canada: Not Cleared
CE: Marked

Captia™ EBV VCA IgG
2325700
96 Tests
Epstein-Barr Virus/Infectious Mononucleosis
Code 2325700
Kit 96 Tests
Disease Epstein-Barr Virus/Infectious Mononucleosis
Intended Use

The Trinity Biotech Captia™ Epstein-Barr Virus Capsid Antigen (EBV VCA) IgG Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the qualitative determination of IgG antibodies to Epstein-Barr virus in human serum. The Trinity Biotech anti-EBV VCA IgG assay may be used in conjunction with other Epstein-Barr serologies as an aid in the diagnosis of infectious mononucleosis in the adult population. For in vitro diagnostic use. High complexity test.

Benefits
Technology
ELISA
Determinations

96 Tests

Application

Infectious Diseases, Virology

Registrations

FDA: Cleared
Canada: Not Cleared
CE: Marked

Captia™ CMV IgM 2-Plate
2325250
96 Tests
Cytomegalovirus (CMV)
Code 2325250
Kit 96 Tests
Disease Cytomegalovirus (CMV)
Intended Use

The Trinity Biotech Captia™ Cytomegalovirus (CMV) IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the qualitative detection of IgM antibody to cytomegalovirus in human serum. For in vitro diagnostic use. High complexity test.

Benefits
Technology
ELISA
Determinations

96 Tests

Application

Infectious Diseases, Virology, ToRCH

Registrations

FDA: Cleared
Canada: Cleared
CE: Not Marked

Documents

IFU Documents

EN Version

 

SDS Documents

EU EN (CLP) Version

HU (CLP) Version

 

 

Captia™ Measles IgM 2-Plate
2326050
96 Tests
Measles
Code 2326050
Kit 96 Tests
Disease Measles
Intended Use

The Trinity Biotech Captia™ Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of Measles IgM antibodies in human serum. For in vitro diagnostic use. High complexity test.

Determinations

96 Tests

Application

Infectious Disease, Virology, MMRV

Technology

ELISA

Registrations

FDA: Not Cleared
Canada: Not Cleared
CE: Marked

Documents
ImmuGlo™ anti-nDNA Antibody IFA Kit Mouse Kidney/Stomach IFA Kit
1106
48 Tests
Systematic Lupus Erythematosus (SLE)
Code 1106
Kit 48 Tests
Disease Systematic Lupus Erythematosus (SLE)
Intended Use

This device is intended for an indirect immunofluorescence antibody test for the detection and quantitation of antibodies to native (double stranded) deoxyribonucleic acid (nDNA) in human serum

Technology

IFA

Determinations

48

Application

Systemic Lupus Erthematosus (SLE)

Registrations

FDA: Cleared

CE:Marked

Canada: Cleared

ImmuGlo™ anti-myelin associated antibody IFA Kit
1172
Provides 48 determinations
Autoimmune Neuropathies
Code 1172
Kit Provides 48 determinations
Disease Autoimmune Neuropathies

This device is intended for the screening and detection by indirect immunofluorescence (IF) of primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum.

Technology
Determinations

Provides 48 determinations

Application

Autoimmune Neuropathies

Registrations

FDA: Not Cleared

CE: Marked

Canada: Not Cleared

Documents
ImmuGlo™ anti-Reticulin antibody (ARA) IFA Kit
1115A-240
Provides 240 determinations
Code 1115A-240
Kit Provides 240 determinations
Intended Use

This device is intended for an indirect immunofluorescence antibody test for the detection and semi-quantitation of anti-reticulin antibodies (ARA) in human serum.

Benefits
Technology
Determinations

Provides 240 determinations

Application

Celiac, Dermatitis Herpetiformis

Registrations

FDA: Not Cleared

CE: Marked

Canada: Not Cleared

Documents
Immunofluorescence Reagent Kit
2600X
Code 2600X
Technology
Determinations
Application
Registrations
Documents
ImmuGlo™ Anti-Skin Antibody (IC/BMZ) Test System
1105
Provides 48 determinations
Code 1105
Kit Provides 48 determinations

This device is intended for an indirect immunofluorescence antibody test for the detection and quantitation of anti-skin (anti-intercellular and anti-basement membrane) antibodies in human serum.

Technology
Determinations

Provides 48 determinations

Application

Vesiculo-bullous, Paraneoplastic Syndromes

Registrations

FDA: Cleared

CE: Marked

Canada: Cleared

Documents

IFU Documents

Anti-Skin Antibody Test System

SDS Documents

ImmuGlo IFA Kits

ImmuGlo™ anti-Endomysial antibody (EMA) IFA Kit
1114A
Provides 48 determinations
Code 1114A
Kit Provides 48 determinations
Intended User

This device is intended for an indirect immunofluorescence antibody test for the qualitative and semi-quantitative detection of endomysial antibodies (EMA) in human serum as an aid in the diagnosis of celiac disease and dermatitis herpetiformis

Technology
Determinations

Provides 48 determinations

Application

Celiac Disease

Registrations

FDA: Not Cleared

CE: Marked

Canada: Not Cleared

Documents

IFU Documents

Antibody Test System

SDS Documents

ImmuGlo IFA Kits

ImmuGlo™ COMVI anti-LKM MouseLiver/Kidney/Stomach IFA Kit
1136C
Provides 48 determinations
Code 1136C
Kit Provides 48 determinations
Technology

Provides 48 determinations

Determinations
Application
Registrations

FDA: Not Cleared

CE: Marked

Canada: Cleared

Documents

IFU Documents

Antibody Test System

SDS Documents

ImmuGlo IFA Kits

ImmuGlo™ Hep-2 Cells – Anti-Nuclear Antibody IFA Kit
1102-60
Provides 60 determinations
Code 1102-60
Kit Provides 60 determinations
Intended Use

The device is intended for indirect immunofluorescence (IF) antibody tests for the detection and quantitation of antinuclear antibodies (ANA) in human serum.

Determinations

Provides 60 determinations

Application

Dermato/Polymyositis, Rheumatoid Artfitis, Scleroderma, Sjogrns Syndrome, Systematic Lupus Erythematosus (SLE)

Registrations

FDA: Cleared

CE: Marked

Canada: Not Cleared

Documents

IFU Documents

Autoantibody Test System

SDS Documents

ImmuGlo IFA Kits

Captia™ Syphilis Total Antibody EIA
2322170/2322171
96 Tests/480 Tests
Syphilis
Code 2322170/2322171
Kit 96 Tests/480 Tests
Disease Syphilis
Intended Use

The Captia™ Syphilis Total Antibody EIA kits is intended for use by appropriately trained and qualified personnel for the detection of antibodies to Treponema pallidum in human serum and plasma. The product may be used for the screening of blood donors, the screening of pregnant women, and to aid in the diagnosis of patients where syphilis infection is suspected.

Benefits
Determinations

96 Tests/480 Tests

Application

Infectious Diseases, Bacteriology, Sexual Health, Blood Donor Screening

Registrations

FDA: Not Cleared
Canada: Not Cleared
CE: Marked

Captia™ NMT Syphilis IgM EIA
2329360
96 Tests
Syphilis
Code 2329360
Kit 96 Tests
Disease Syphilis
Intended Use

The Captia™ NMT Syphilis IgM EIA is intended for the detection of IgM specific antibodies to Treponema pallidum (T. pallidum) in human serum or plasma and is used in the differential diagnosis of syphilis infections.

Benefits
Determinations

96 Tests

Application

Infectious Diseases, Bacteriology, Sexual Health

Registrations

FDA Not Cleared,
Canada Not Cleared,
CE Marked

ImmuLisa™ SS-B (La) Antibody EL
5129
96 Tests
Sjögren's Syndrome,  Systemic Lupus Erythematosus (SLE)
Code 5129
Kit 96 Tests
Disease Sjögren's Syndrome,  Systemic Lupus Erythematosus (SLE)
Intended Use

Enzyme linked immunoassays (ELISA) for the detection and semi-quantitation of SS-B (La) antibodies in human serum as an aid in diagnosis of Systemic Lupus Erythematosus (SLE) and associated connective tissue disorders.

Benefits
Special Notation

Special Order

Technology

EIA

Determinations

96

Application

Sjögren’s Syndrome,  Systemic Lupus Erythematosus (SLE)

Registrations

FDA: Cleared

Canada: Not Cleared

CE Marked

Captia™ Malaria Total Antibody EIA
2322470/2322471
96 Tests/480 Tests
Malaria
Code 2322470/2322471
Kit 96 Tests/480 Tests
Disease Malaria
Intended Use

The Captia™ Malaria Total Antibody EIA is intended for use by appropriately trained and qualified personnel for the qualitative and semi-quantitative detection of antibodies to P.falciparum, P.vivax, P.ovale and P.malariae in human serum and plasma.

Benefits
Determinations

96 Tests/480 Tests

Application

Infectious Diseases

Registrations

FDA: Not Cleared
Canada: Not Cleared
CE: Marked

NCS FTY One Step Fentanyl Test Device
DFT-102
40 tests
qualitative detection of Fentanyl and Fentanyl metabolites
Code DFT-102
Kit 40 tests
Disease qualitative detection of Fentanyl and Fentanyl metabolites
Intended Use

A rapid, one step screening test for the, qualitative detection of Fentanyl and Fentanyl metabolites in human urine.

Technology

lateral flow chromatographic immunoassay

Determinations

40 tests

Application

qualitative detection of Fentanyl and Fentanyl metabolites

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Confirm 5, Cutoff +25%
DOAC-18008615
50 ml
Drugs of abuse, Confirm 5 HIGH OPIATE
Code DOAC-18008615
Kit 50 ml
Disease Drugs of abuse, Confirm 5 HIGH OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, Confirm 5 HIGH OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Confirm 5, Cutoff -60%
DOAC-18008614
50 ml
Drugs of abuse, Confirm 5 HIGH OPIATE
Code DOAC-18008614
Kit 50 ml
Disease Drugs of abuse, Confirm 5 HIGH OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, Confirm 5 HIGH OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control GC/MS MIX
DOAC-18002988
20 ml
Drugs of abuse, GC/MS MIX
Code DOAC-18002988
Kit 20 ml
Disease Drugs of abuse, GC/MS MIX
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

20 ml

Application

Drugs of abuse, GC/MS MIX

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Pain MGMT High Opiate
DOAC-18005117
20 ml
Drugs of abuse, Pain MGMT
Code DOAC-18005117
Kit 20 ml
Disease Drugs of abuse, Pain MGMT
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

20 ml

Application

Drugs of abuse, Pain MGMT

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Pain MGMT Low Opiate
DOAC-18005116
20 ml
Drugs of abuse, Pain MGMT
Code DOAC-18005116
Kit 20 ml
Disease Drugs of abuse, Pain MGMT
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

20 ml

Application

Drugs of abuse, Pain MGMT

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control GC/MS-H +25%
DOAC-19572753
50 ml
Drugs of abuse, GC/MS HIGH OPIATE
Code DOAC-19572753
Kit 50 ml
Disease Drugs of abuse, GC/MS HIGH OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, GC/MS HIGH OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control GC/MS-H Cutoff
DOAC-19572502
50 ml
Drugs of abuse, GC/MS HIGH OPIATE
Code DOAC-19572502
Kit 50 ml
Disease Drugs of abuse, GC/MS HIGH OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, GC/MS HIGH OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control GC/MS-H -25%
DOAC-19572251
50 ml
Drugs of abuse, GC/MS HIGH OPIATE
Code DOAC-19572251
Kit 50 ml
Disease Drugs of abuse, GC/MS HIGH OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, GC/MS HIGH OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control GC/MS +25%
DOAC-19332501
50 ml
Drugs of abuse, GC/MS LOW OPIATE
Code DOAC-19332501
Kit 50 ml
Disease Drugs of abuse, GC/MS LOW OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, GC/MS LOW OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control GC/MS -25%
DOAC-19332001
50 ml
Drugs of abuse, GC/MS LOW OPIATE
Code DOAC-19332001
Kit 50 ml
Disease Drugs of abuse, GC/MS LOW OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, GC/MS LOW OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control GC/MS
DOAC-19330000
50 ml
Drugs of abuse, GC/MS LOW OPIATE
Code DOAC-19330000
Kit 50 ml
Disease Drugs of abuse, GC/MS LOW OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, GC/MS LOW OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Confirm 4 +25%
DOAC-19582126
50 ml
Drugs of abuse, Confirm 4 HIGH OPIATE
Code DOAC-19582126
Kit 50 ml
Disease Drugs of abuse, Confirm 4 HIGH OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, Confirm 4 HIGH OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Confirm 4 -60%
DOAC-19582041
50 ml
Drugs of abuse, Confirm 4 HIGH OPIATE
Code DOAC-19582041
Kit 50 ml
Disease Drugs of abuse, Confirm 4 HIGH OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, Confirm 4 HIGH OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Confirm 4 -25%
DOAC-19582026
50 ml
Drugs of abuse, Confirm 4 HIGH OPIATE
Code DOAC-19582026
Kit 50 ml
Disease Drugs of abuse, Confirm 4 HIGH OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, Confirm 4 HIGH OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Confirm 4 Cutoff
DOAC-19582002
50 ml
Drugs of abuse, Confirm 4 HIGH OPIATE
Code DOAC-19582002
Kit 50 ml
Disease Drugs of abuse, Confirm 4 HIGH OPIATE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, Confirm 4 HIGH OPIATE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control 2X Cutoff MDMA/Oxycodone
DOAC-2XMO
5 ml
Drugs of abuse, Immunoassay Urine Toxicology
Code DOAC-2XMO
Kit 5 ml
Disease Drugs of abuse, Immunoassay Urine Toxicology
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

5 ml

Application

Drugs of abuse, Immunoassay Urine Toxicology

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Negative Control Urine
DOAC-19227000
50 ml
Drugs of abuse, NEGATIVE
Code DOAC-19227000
Kit 50 ml
Disease Drugs of abuse, NEGATIVE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

50 ml

Application

Drugs of abuse, NEGATIVE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Negative Control Urine
DOAC-000-1
5 ml
Drugs of abuse, NEGATIVE
Code DOAC-000-1
Kit 5 ml
Disease Drugs of abuse, NEGATIVE
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

5 ml

Application

Drugs of abuse, NEGATIVE

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control MDMA and Oxycodone
DOAC-050MO
5 ml
Drugs of abuse, Immunoassay Urine Toxicology
Code DOAC-050MO
Kit 5 ml
Disease Drugs of abuse, Immunoassay Urine Toxicology
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

5 ml

Application

Drugs of abuse, Immunoassay Urine Toxicology

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control Fentanyl (norfentanyl)
DOAC-F
5 ml
Drugs of abuse, Immunoassay Urine Toxicology
Code DOAC-F
Kit 5 ml
Disease Drugs of abuse, Immunoassay Urine Toxicology
Intended Use

DOA URINE TOXICOLOGY LIQUID CONTROL, Positive, Fentanyl (norfentanyl). The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

5 ml

Application

Drugs of abuse, Immunoassay Urine Toxicology

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS DOA Urine Toxicology Liquid Control
DOAC-2XMOB
5 ml
Drugs of abuse, Immunoassay Urine Toxicology
Code DOAC-2XMOB
Kit 5 ml
Disease Drugs of abuse, Immunoassay Urine Toxicology
Intended Use

The DOA Urine Toxicology Controls are intended for use as quality control urine to monitor the precision of laboratory urine toxicology testing procedures for the analytes listed in the package insert. Each bottle contains stabilized human based urine.

Technology

qualitative or quantitative procedures for the detection of drugs in urine

Determinations

5 ml

Application

Drugs of abuse, Immunoassay Urine Toxicology

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS BUP One Step Buprenorphine Test Device
DBU-102
40 tests
detection of Buprenorphine
Code DBU-102
Kit 40 tests
Disease detection of Buprenorphine
Intended Use

A rapid, one step test for the qualitative detection of Buprenorphine in human urine

Technology

lateral flow chromatographic immunoassay

Determinations

40 tests

Application

detection of Buprenorphine

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

ENFR

SDS Documents

Available Upon Request

NCS One Step Multi-Line Screen Test Device (Urine)
DOA-1115
25 tests
Qualitative detection of multiple drugs and drug metabolites in human urine.
Code DOA-1115
Kit 25 tests
Disease Qualitative detection of multiple drugs and drug metabolites in human urine.
Intended Use

A rapid one step test device for testing combinations of the following drugs: Amphetamine, Barbiturates,
Benzodiazepines, Cocaine, Marijuana, Methadone, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Oxycodone, and Tricyclic Antidepressants.

This test will detect other related compounds, please refer to the Analytical Specificity table in the package insert. This assay provides only a preliminary analytical test result. Gas chromatography/ mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

Technology

Rapid immunoassay

Determinations

25 tests

Application

Qualitative detection of multiple drugs and drug metabolites in human urine.

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

DOA1115

SDS Documents

Available Upon Request

NCS pregnancy hcg liquid urine control (negative)
18000177
5 ml
PREGNANCY HCG
Code 18000177
Kit 5 ml
Disease PREGNANCY HCG
Intended Use

The N.C.S. hCG negative control – urine is intended to validate the performance of qualitative urinary hCG methods.

Technology

intended to validate the performance of qualitative urinary hCG methods

Determinations

5 ml

Application

PREGNANCY HCG

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

HCG URINE

SDS Documents

Available Upon Request

NCS pregnancy hcg liquid urine control (low positive)
18000176
5 ml
PREGNANCY HCG
Code 18000176
Kit 5 ml
Disease PREGNANCY HCG
Intended Use

The N.C.S. hCG positive control – urine is intended to validate the performance of qualitative urinary hCG methods. Low Positive control 25mIU/mL

Technology

intended to validate the performance of qualitative urinary hCG methods

Determinations

5 ml

Application

PREGNANCY HCG

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

HCG URINE

SDS Documents

Available Upon Request

NCS One Step Pregnancy Test Device
NCS-1050
50 tests
early detection of pregnancy
Code NCS-1050
Kit 50 tests
Disease early detection of pregnancy
Intended Use

The hCG One Step Pregnancy Test device (urine/serum) is a rapid chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin in urine or serum to aid in the early detection of pregnancy.

Technology

Rapid immunoassay

Determinations

50 tests

Application

early detection of pregnancy

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

NCS-1040

SDS Documents

Available Upon Request

NCS One Step Pregnancy Test Device
NCS-1025
25 tests
early detection of pregnancy
Code NCS-1025
Kit 25 tests
Disease early detection of pregnancy
Intended Use

The hCG One Step Pregnancy Test device (urine/serum) is a rapid chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin in urine or serum to aid in the early detection of pregnancy.

Technology

Rapid immunoassay

Determinations

25 tests

Application

early detection of pregnancy

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

NCS-1040

SDS Documents

Available Upon Request

NCS One Step Pregnancy Test Device
NCS-500
500 tests
early detection of pregnancy
Code NCS-500
Kit 500 tests
Disease early detection of pregnancy
Intended Use

The hCG One Step Pregnancy Test device (urine/serum) is a rapid chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin in urine or serum to aid in the early detection of pregnancy.

Technology

Rapid immunoassay

Determinations

500 tests

Application

early detection of pregnancy

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

NCS-1040

SDS Documents

Available Upon Request

NCS One Step Pregnancy Test Device
NCS-1100
100 tests
early detection of pregnancy
Code NCS-1100
Kit 100 tests
Disease early detection of pregnancy
Intended Use

The hCG One Step Pregnancy Test device (urine/serum) is a rapid chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin in urine or serum to aid in the early detection of pregnancy.

Technology

Rapid immunoassay

Determinations

100 tests

Application

early detection of pregnancy

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

NCS-1040

SDS Documents

Available Upon Request

NCS One Step Pregnancy Test Device
NCS-1040
40 tests
early detection of pregnancy
Code NCS-1040
Kit 40 tests
Disease early detection of pregnancy
Intended Use

The hCG One Step Pregnancy Test device (urine/serum) is a rapid chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin in urine or serum to aid in the early detection of pregnancy.

Technology

Rapid immunoassay

Determinations

40 tests

Application

early detection of pregnancy

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

NCS-1040

SDS Documents

Available Upon Request

NCS Rapid test for Malaria Pan/Pf
MAL10025-10
10 tests
Malaria Pan/Pf
Code MAL10025-10
Kit 10 tests
Disease Malaria Pan/Pf
Intended Use

Rapid Test For Malaria Pan/Pf is a rapid, qualitative, two site sandwich immunoassay, utilizing whole blood for the detection of P.falciparum specific histidine rich protein-2 (Pf HRP-2) and Pan malaria specific pLDH. The test may also be used for differentiation of P. falciparum and other malarial species and for the follow up of antimalarial therapy in whole blood samples.

Technology

Rapid immunoassay

Determinations

10 tests

Application

Malaria Pan/Pf

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

MAL10025

SDS Documents

Available Upon Request

NCS Rapid test for Malaria Pan/Pf
MAL10025
25 tests
Malaria Pan/Pf
Code MAL10025
Kit 25 tests
Disease Malaria Pan/Pf
Intended Use

Rapid Test For Malaria Pan/Pf is a rapid, qualitative, two site sandwich immunoassay, utilizing whole blood for the detection of P.falciparum specific histidine rich protein-2 (Pf HRP-2) and Pan malaria specific pLDH. The test may also be used for differentiation of P. falciparum and other malarial species and for the follow up of antimalarial therapy in whole blood samples.

Technology

Rapid immunoassay

Determinations

25 tests

Application

Malaria Pan/Pf

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

MAL10025

SDS Documents

Available Upon Request

NCS Diluent buffer for Rapid test for Malaria Pan/Pf
MAL-339
4 ml
Malaria Pan/Pf
Code MAL-339
Kit 4 ml
Disease Malaria Pan/Pf
Intended Use

Test kit component

Technology

Rapid immunoassay

Determinations

4 ml

Application

Malaria Pan/Pf

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

MAL10025

SDS Documents

Available Upon Request

NCS Diluent buffer for Rapid test for P.falciparum malaria
MAL-338
4 ml
Plasmodium falciparum malaria
Code MAL-338
Kit 4 ml
Disease Plasmodium falciparum malaria
Intended Use

Test kit component

Technology

Rapid immunoassay

Determinations

4 ml

Application

Plasmodium falciparum malaria

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

MAL025

SDS Documents

Available Upon Request

NCS Rapid test for P. falciparum malaria
MAL025
25 tests
Plasmodium falciparum malaria
Code MAL025
Kit 25 tests
Disease Plasmodium falciparum malaria
Intended Use

Rapid test for P. falciparum malaria-Device is a rapid, qualitative, two site sandwich immunoassay for the determination of P. falciparum specific histidine rich protein-2 (Pf HRP-2) in whole blood for the diagnosis of falciparum malaria in individuals with signs and symptoms consistent with malaria infection

Technology

Rapid immunoassay

Determinations

25 tests

Application

Plasmodium falciparum malaria

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

MAL025

SDS Documents

Available Upon Request

NCS Rapid test for P. falciparum malaria
MAL010
10 tests
Plasmodium falciparum malaria
Code MAL010
Kit 10 tests
Disease Plasmodium falciparum malaria
Intended Use

Rapid test for P. falciparum malaria-Device is a rapid, qualitative, two site sandwich immunoassay for the determination of P. falciparum specific histidine rich protein-2 (Pf HRP-2) in whole blood for the diagnosis of falciparum malaria in individuals with signs and symptoms consistent with malaria infection

Technology

Rapid immunoassay

Determinations

10 tests

Application

Plasmodium falciparum malaria

Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

MAL025

SDS Documents

Available Upon Request

ImmuGlo™ Primate Heart Slide
2157
6 wells
Code 2157
Kit 6 wells
Intended Use
Technology

IFA

Determinations

6 wells

Application
Registrations

FDA Not Cleared, CE Marked Canada Not Cleared

Documents
NCS Mononucleosis Rapid Test Device
IMO-402
20 tests
Infectious Mononucleosis
Code IMO-402
Kit 20 tests
Disease Infectious Mononucleosis
Intended Use

The MONO Mononucleosis Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of Infectious Mononucleosis heterophile antibodies in whole blood, serum or plasma as an aid in the diagnosis of Infectious Mononucleosis.

Technology

Rapid immunoassay

Determinations

20 tests

Application
Registrations

Canada Cleared, Not FDA Cleared, Not CE Cleared

Documents

IFU Documents

IFU ENG FR Version

SDS Documents

Available Upon Request

ImmuGlo™ Optical Standard Slide
2550OS
8 wells
Code 2550OS
Kit 8 wells
Intended Use
Technology

IFA

Determinations

8 wells

Application
Registrations

FDA Cleared, CE Marked Canada Not Cleared

ImmuGlo™ Primate Pancreas Slide
2165
4 wells
Code 2165
Kit 4 wells
Intended Use
Technology

IFA

Determinations

4 wells

Application
Registrations

FDA Not Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Substrate Slides

Substrate Slides, Plates, and Strips

 

ImmuGlo™ Rat Kidney Slide
2161
6 wells
Code 2161
Kit 6 wells
Intended Use
Technology

IFA

Determinations

6 wells

Application
Registrations

FDA Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Substrate Slides

Substrate Slides, Plates, and Strips

 

ImmuGlo™ Primate Skeletal Slide
2158
6 wells
Code 2158
Kit 6 wells
Intended Use
Technology

IFA

Determinations

6 wells

Application
Registrations

FDA Not Cleared, CE Marked Canada Not Cleared

Documents
ImmuGlo™ Transitional Epithelium Slide
2156
6 wells
Code 2156
Kit 6 wells
Intended Use
Technology

IFA

Determinations

6 wells

Application
Registrations

FDA: Not Cleared

CE: Marked

Canada: Not Cleared

Documents
ImmuGlo™ Primate Esophagus (Distal) Slide
2155-1
8 wells
Code 2155-1
Kit 8 wells
Intended Use
Technology

IFA

Determinations

8 wells

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Substrate Slides

Substrate Slides, Plates, and Strips

 

ImmuGlo™ Mouse Kidney/Stomach Slide
2152
12 wells
Code 2152
Kit 12 wells
Intended Use
Technology

IFA

Determinations

12 wells

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Substrate Slides

Substrate Slides, Plates, and Strips

 

ImmuGlo™ Primate Split Skin Slide
2147
6 wells
Code 2147
Kit 6 wells
Intended Use
Technology

IFA

Determinations

6 wells

Application
Registrations

FDA Not Cleared, CE Marked Canada Cleared

Documents
ImmuGlo™ Primate Cerebellum Slide
2128
6 wells
Code 2128
Kit 6 wells
Intended Use
Technology

IFA

Determinations

6 wells

Application
Registrations

FDA Not Cleared, CE Marked Canada Cleared

Documents
ImmuGlo™ Primate Adrenal Gland Slide
2123
6 wells
Code 2123
Kit 6 wells
Intended Use
Technology

IFA

Determinations

6 wells

Application
Registrations

FDA Not Cleared, CE Marked Canada Not Cleared

Documents
ImmuGlo™ Ribosomal P Positive Control
2261
0.5 ml
Code 2261
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Not Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ cANCA Positive Control
2252
0.5 ml
Code 2252
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ pANCA Positive Control
2240
0.5 ml
Code 2240
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ anti-Thyroid Positive Control
2239
0.5 ml
Code 2239
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

 

ImmuGlo™ anti-Islet Cell Positive Control
2233
0.5 ml
Code 2233
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Not Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ Pemphigus Foliaceus Positive Control
2216
0.5 ml
Code 2216
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

Generic

SDS Documents

Wash Buffer

ImmuGlo™ nDNA Positive Control
2215
0.5 ml
Code 2215
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ Pemphigus Vulgaris Positive Control
2214
0.5 ml
Code 2214
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA: Cleared

CE: Marked

Canada: Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

 

ImmuGlo™ Intercellular Positive
2213
0.5 ml
Code 2213
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

 

ImmuGlo™ MAG Positive Control
2209
0.5 ml
Code 2209
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Not Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

 

ImmuGlo™ ANA Positive Control
2205
0.5 ml
Code 2205
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

ANA Positive Pattern Controls

SDS Documents

Positive Control

 

ImmuGlo™ ANA Positive Control
2204
0.5 ml
Code 2204
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

ANA Positive Pattern Controls

SDS Documents

Positive Control

 

ImmuGlo™ ExPA Positive Control
1194-2
0.5 ml
Code 1194-2
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Not Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ ARA Positive Control
2251
0.5 ml
Code 2251
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ EMA (IgG) Positive Control
2250G
0.5 ml
Code 2250G
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

EMA Positive Control IFA

 

ImmuGlo™ EMA Positive Control
2250
0.5 ml
Code 2250
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared

CE Marked

Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

EMA Positive Control IFA

 

ImmuGlo™ Anti-Keratin Positive Control
2245
0.5 ml
Code 2245
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Not Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ LKM Positive Control
2242
0.5 ml
Code 2242
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Not Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ Paraneoplastic/Pemphigus Positive Control
2241
0.5 ml
Code 2241
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Not Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

 

ImmuGlo™ PCNA Positive Control
2236
0.5 ml
Code 2236
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Not Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

Available upon request

SDS Documents

Positive Control

 

ImmuGlo™ heart/skeletal-positive-control
2235
0.5 ml
Code 2235
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Not Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

ImmuGlo™ Pemphigoid Positive
2217
0.5 ml
Code 2217
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

 

ImmuGlo™ AGPA Positive Control
2212
0.5 ml
Code 2212
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

 

ImmuGlo™ ASMA Positive Control
2211
0.5 ml
Code 2211
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

 

ImmuGlo™ AMA Positive Control
2210
0.5 ml
Code 2210
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

SDS Documents

Positive Control

 

ImmuGlo™ ANA Positive Control
2203
0.5 ml
Code 2203
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

ANA Positive Pattern Controls

SDS Documents

Positive Control

 

ImmuGlo™ Low Titer ANA Positive Control
2201-1
0.5 ml
Code 2201-1
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations
Documents

IFU Documents

SDS Documents

Positive Control

 

ImmuGlo™ ANA Positive Control
2201
0.5 ml
Code 2201
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

ANA Positive Pattern Controls

SDS Documents

Positive Control

 

ImmuGlo™ Negative Control
2200
0.5 ml
Code 2200
Kit 0.5 ml
Intended Use
Technology

IFA

Determinations

0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

SDS Documents

Negative Controls

 

ImmuGlo™ ANA Pattern Control Panel I
1602
5 x 0.5 ml
Code 1602
Kit 5 x 0.5 ml
Intended Use
Technology

IFA

Determinations

5 x 0.5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Not Cleared

Documents

IFU Documents

ANA Positive Pattern Controls

SDS Documents

IFA Kits

ImmuGlo™ Mounting Medium
2505
60 ml
Code 2505
Kit 60 ml
Intended Use
Technology

IFA

Determinations

5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents
ImmuGlo™ Buffered Diluent
2302
60 ml
Code 2302
Kit 60 ml
Intended Use
Technology

IFA

Determinations

60 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

SDS Documents

Buffered Diluent

ImmuGlo™ Phosphate Buffered Saline
2301
1 litre
Code 2301
Kit 1 litre
Intended Use
Technology

IFA

Determinations

For 1 litre

Application
Registrations

FDA: Cleared

CE: Marked

Canada: Cleared

Documents

IFU Documents

Generic

SDS Documents

Wash Buffer

ImmuGlo™ IgG FITC Conjugate w/Evans Blue
2107
5 ml
Code 2107
Kit 5 ml
Intended Use
Technology

IFA

Determinations

5 ml

Application
Registrations

FDA Cleared, CE Marked Canada Cleared

Documents

IFU Documents

Generic

SDS Documents

Conjugates

Find a distributor in your area

List view
Map view
Featured Image
test20 Biomedica Medizinprodukte GmbH 4
Scottgasse 8, 1210 Wien, cork
Featured Image
test19 Biomedica Medizinprodukte GmbH 4
Scottgasse 8, 1210 Wien, cork
Featured Image
test16 Biomedica Medizinprodukte GmbH 3
Trillergasse 8, 1210 Wien, Dublin
Featured Image
test15 Biomedica Medizinprodukte GmbH 3
Trillergasse 8, 1210 Wien, cork
Featured Image
test12 Biomedica Medizinprodukte GmbH 2
Shuttleworthstraße 25, 1210 Wien, Dublin
Featured Image
test18 Biomedica Medizinprodukte GmbH 4
Scottgasse 8, 1210 Wien, Dublin
Featured Image
test14 Biomedica Medizinprodukte GmbH 3
Trillergasse 8, 1210 Wien, Dublin
Featured Image
test11 Biomedica Medizinprodukte GmbH 2
Shuttleworthstraße 25, 1210 Wien, cork
Featured Image
demo10 Biomedica Medizinprodukte GmbH 2
Shuttleworthstraße 25, 1210 Wien, Dublin
Featured Image
demo6 Biomedica Medizinprodukte GmbH 1
Neudorfergasse 1, 1210 Wien, cork
Featured Image
demo7 Biomedica Medizinprodukte GmbH 1
Neudorfergasse 1, 1210 Wien, Dublin
Featured Image
demo8 Biomedica Medizinprodukte GmbH 1
Neudorfergasse 1, 1210 Wien, cork
Featured Image
demo4 Biomedica Medizinprodukte GmbH
Divischgasse 4, 1210 Wien, cork
Featured Image
demo3 Biomedica Medizinprodukte GmbH
Divischgasse 4, 1210 Wien, Dublin
Featured Image
demo2 Biomedica Medizinprodukte GmbH
Divischgasse 4, 1210 Wien, cork
Featured Image
test17 Biomedica Medizinprodukte GmbH 4
Scottgasse 8, 1210 Wien, cork
Featured Image
test13 Biomedica Medizinprodukte GmbH 3
Trillergasse 8, 1210 Wien, cork
Featured Image
demo9 Biomedica Medizinprodukte GmbH 2
Shuttleworthstraße 25, 1210 Wien, Dublin
Featured Image
demo5 Biomedica Medizinprodukte GmbH 1
Neudorfergasse 1, 1210 Wien, Dublin
Featured Image
demo1 Biomedica Medizinprodukte GmbH
Divischgasse 4, 1210 Wien, cork